In the TME, up-regulation of PD-1 on T cells occurs in response to activation due to tumor antigens (87), while overexpression of its ligands (PD-L1 and PD-L2) on cancer cells is a well-known immune escape mechanism (88). Here, PDCD1 is linked to neoplasm.